Approval · Notice of Compliance 34356 · 2024
LETYBO: Notice of Compliance 34356
Issued November 7, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34356
- Date
- November 7, 2024
- Company
- Hugel Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Manufacturer name change
Products in this notice
Medicinal ingredients
- LETIBOTULINUMTOXINA 50 UNIT per VIAL
- LETIBOTULINUMTOXINA 100 UNIT per VIAL